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Abstract
Aim The aim of this paper is to describe the Generation R
study as a template that enables candidate gene study and
genome-wide association study regarding health-related
quality of life (HRQOL) of mothers and their young
children.
Methods Generation R is a population-based prospective
cohort study from fetal life onwards in Rotterdam, The
Netherlands. Children were born in 2002–2006. Blood
from mothers and placenta cord blood were sampled.
Mothers’ HRQOL was measured 5 times during pregnancy
and after birth using SF-12 and EQ-5D. Children’s
HRQOL was measured 5 times between age 1 and
5/6 years using Infant-Toddler Quality Of Life question-
naire (ITQOL), Health Status Classification System
PreSchool (HSCS-PS) and Child Health Questionnaire
Parent Form 28 items (CHQ-PF28), respectively.
Results DNA is available for 8,055 mothers and 5,908
children. Genotyping of various candidate genes and a
genome-wide association (GWA) scan (Illumina 610K) of
child DNA were done. A template for gene-HRQOL
analyses is provided. We start with candidate gene study on
HRQOL of mothers and children. Gene–environment
interaction and interaction with medical indicators of
health status will be explored. Next, GWA study on
HRQOL will be performed.
Conclusions Gaining insight into the determinants of
HRQOL is essential to assisting efforts in health policy and
clinical application to improve well-being and health. In
the future, it might be possible to complement HRQOL
assessments by examinations of genetic markers. Strengths
and weaknesses of the Generation R study are discussed.
Keywords Genetic factors  Genome-wide association
study (GWAS)  Health-related quality of life 
Mothers  Children
Introduction
Quality of life may be defined as ‘individuals’ perceptions
of their position in life in the context of the culture and
value systems in which they live and in relation to their
goals, expectations, standards and concerns (WHO Quality
of Life group definition [1]), or as ‘physical, social
and emotional aspects of well-being that are relevant
and important to the individual’ [2]. As such, it is a
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multi-dimensional concept. There are validated question-
naires for adults as well as for adolescents, children,
infants and toddlers to measure health-related quality of
life (HRQOL) [3, 4]. The relevant dimensions and the
item content of pediatric quality of life questionnaires
differ from those applied in adult questionnaires and vary
with developmental age [4]. In young children, it is
indispensable to use a proxy rater to complete the HRQOL
questionnaire; the proxy rater generally is one of the
parents [3].
Health-related quality of life may be studied either in
general population samples or in clinical samples of
patients. At the general population level, the purpose of
such studies is often to monitor the health status and well-
being; for the purpose of public health policy, it is
important to know the determinants of HRQOL in order to
develop public health policies [5, 6]. With regard to
patients with a certain medical condition, clinicians assess
the impact of the condition on HRQOL and the factors that
determine quality of life in order to find ways for
improving the patients’ well-being [7–10]. In the case of
intensive or new therapies, clinicians monitor the impact of
therapy on HRQOL [11–13]. In clinical trials, HRQOL is
an outcome measure, complementary to clinical measures
and mortality [3].
While in general population studies and in clinical
studies, the major determinants of health-related quality of
life have been identified, i.e., the severity and duration of
symptoms, the effects of specific medical interventions,
socio-demographic and -economic characteristics such as
gender, age, education and income level, as well as certain
psychosocial aspects such as social support and stressful
life events, only little is known about potential genetic
aspects [14, 15]. The GENEQOL consortium was estab-
lished to investigate the genetic disposition of HRQOL and
other related patient-reported outcomes in addition to the
known determinants of quality of life [14, 15]. The con-
sortium hypothesizes that since concepts that are closely
related to HRQOL, such as negative and positive psycho-
logical affect, major depressive disorder, poor self-rated
physical health, pain and fatigue have genetic components
[15–19], it is likely that genes can be found that are
associated with HRQOL.
The ultimate goal of gaining insight into the genetic
disposition of HRQOL is to find better ways to improve
general health, well-being and quality of life by targeting
subgroups that may benefit from specific interventions. The
first step is a candidate gene approach, which includes
empirical research across multiple datasets to establish
whether a proposed list of potentially relevant genetic
factors reveals genes that are statistically significantly
associated with specific domains of HRQOL [15]. In a
second phase, as suggested by the GENEQOL consortium,
genome-wide association studies in large samples are
needed to identify potential genetic factors that affect
HRQOL. Replication of results in independent samples is
required.
The Generation R study, a prospective population-based
cohort study that was designed to identify early environ-
mental and genetic causes of normal and abnormal growth,
development and health from fetal life onwards, is appro-
priate to contribute to the study of genetic factors related to
HRQOL of mothers and children. The study has previously
been described in detail [20–22]. The focus of this paper is
to discuss how HRQOL data can be integrated into genetic
research. We describe the Generation R study as an
example of a cohort study enabling candidate gene studies
and genome-wide association studies of HRQOL of both
mothers and their young children.
Methods
Design and participants
The Generation R study was conducted in Rotterdam, the
Netherlands, in a multi-ethnic metropolitan area. Pregnant
women were informed about the study and invited to
provide written informed consent by their prenatal care
provider during the first visit in pregnancy. The study area
includes approximately 350.000 inhabitants of circa 150
different ethnicities [23]. The Generation R study was
conducted in accordance with the guidelines proposed in
the World Medical Association Declaration of Helsinki
and has been approved by the Medical Ethical Commit-
tee of the Erasmus MC, University Medical Center
Rotterdam.
Mothers in the study area with a delivery date between
April 2002 and January 2006 were eligible for participa-
tion. The majority of mothers were enrolled during early
pregnancy (gestational age \18 weeks). Fathers were
invited to participate but did not complete HRQOL
questionnaires.
Assessments during pregnancy, including questionnaires
with regard to maternal HRQOL, took place in early
pregnancy (gestational age \18 weeks), mid-pregnancy
(gestational age 18–25 weeks) and late pregnancy (gesta-
tional age[25 weeks). At ages 2, 6, 12, 18, 24, 30, 36 and
48 months, parents (most often mothers) completed ques-
tionnaires for themselves and their infant. Furthermore,
data were collected during routine visits to the preventive
child health centers at ages 1, 2, 3, 4, 6, 11, 14, 18, 24, 30,
36 and 45 months, respectively. At age 5/6 years, data
were collected during a visit of the parent and child to the
Erasmus Medical Center using hands-on measurements and
standardized parent-completed questionnaires.
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Health-related quality of life of the mothers
In early pregnancy (gestational age \18 weeks), we
administered the SF-12, 3 additional items of the SF-36
mental health scale [24–27], the EQ-5D and a visual ana-
logue scale (VAS) on general health of the mother [24, 28,
29]. At mid-pregnancy and at late pregnancy, the SF-12
and the entire SF-36 mental health scale were administered
again. Two months after the child’s birth, all measures
were repeated, but at the 6–month-postbirth assessment,
only the SF-12 was administered.
The SF-12, and even more the EQ-5D, may show ceiling
effects in general population samples; in subgroups with ill
health, especially the SF-12 may be subject to floor effects
[30]. Thus, during the analytic phase of the project, it will
be essential to determine the range of health status out-
comes for both the SF-12 and the EQ-5D. In addition to the
SF-12 summary score formulas proposed by Ware et al.
that are calculated by adding up positive weights and
subtracting negative weights, we will also apply the
RAND-12 formulas to calculate summary scores that only
use positive weights, since some studies have shown that
the SF-12 physical and mental domains may interact [31].
Health-related quality of life of the children
Age 12 months: At age 12 months, we applied the Infant-
Toddler Quality of Life (ITQOL) questionnaire. This is a
parent-completed generic HRQOL measure for infants and
toddlers aged 2 months up to 5 years of age [32–35]. The
ITQOL consists of 103 items with four, five or six Likert-
type response options, divided over ten multi-item scales
and two single-item scales. The ITQOL can be considered
a ‘health profile measure’ [2, 4]. The ITQOL includes
scales on physical and psychosocial functioning of the
child, as well as on the impact of child health and disease
on parental and family functioning.
Age 24 months: To reduce respondent burden and in the
absence of a short form of the ITQOL at the time of the
study, a factor analytic approach using a prior general
population sample [33] was applied to reduce the number
of items to be fielded at the follow-up at age 24 months in
the Generation R study; 55 items that captured all ITQOL
concepts were retained for the purpose of this study only.
Before using this ad-hoc short form in future analyses, it is
necessary to assess whether the revised version represents
the original full length version of the ITQOL and a future
final short form of the ITQOL; in the Generation R sample
(at age 12 months and age 24 months) and in other studies
in which the ITQOL was applied, we propose to evaluate
how well the new scorings represent the original scores.
Age 36 months: At the child age of 36 months, we
applied a ‘preference-based measure’ of HRQOL, [2, 4], the
Health Status Classification System for preschool children
(HSCS-PS), suitable for children aged 2.5–5 years. The
HSCS-PS has 12 dimensions and 3–5 levels per dimension
[4, 36–38]. For the purpose of the Generation R study, the
parent questionnaire that can be used to classify children
according to the HSCS-PS was translated into Dutch fol-
lowing international standards including four forward and
two independent backward translations [39].
Age 48 months and age 5/6 years: At both the child age
of 48 months and at age 5/6 years, we applied a ‘health
profile measure’, i.e., the Child Health Questionnaire Par-
ent Form with 28 items (CHQ-PF28), which has been
developed for ages 5 and older [5, 40–42]. In the Nether-
lands, the CHQ-PF has been validated for children aged
4 years and older [5]. Like the ITQOL, it covers physical
and psychosocial aspects. The CHQ-PF28 permits the
calculation of a physical and a psychosocial summary
score.
DNA of the mothers and children
Maternal blood samples were collected in early (approxi-
mately 35 ml) and mid-pregnancy (approximately 20 ml)
during the visit to one of the dedicated research centers.
Directly after delivery, midwives or obstetricians collected
30-ml cord blood from the umbilical vein. The samples
were transported on average within 2 h to the Generation R
laboratory. Ten-ml EDTA tube per mother and child was
provided for DNA extraction; these samples were stored
at Erasmus MC, University Medical Center Rotterdam at
-80C [21].
Information on health status and determinants of health
In the Generation R study, information has been gathered
on the health status of mothers during pregnancy and the
postpartum period using 3 prenatal questionnaires and
questionnaires 2 and 6 months postpartum with regard to
the presence of chronic conditions, symptoms and use of
medical services, and using medical information form the
patient files and the birth record of the midwife, obstetri-
cian and hospital. During pregnancy, the mothers visited
our study center three times and had standardized measures
of height, weight, blood pressure and fetal ultrasounds;
urine and blood samples were collected [20–22].
The three fetal ultrasounds also provide information on
the fetal growth of the children. Until age 6 years, parents
complete 10 paper questionnaires including health-related
items with regard to their child, including items on
symptoms, periods of fever and infections, chronic condi-
tions and use of medical services [20–22]. Data with regard
to the growth, development and health status of the chil-
dren were collected during free routine visits to the
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preventive child health centers, up to 13 preventive health
visits until age 6 years. At age 5/6 years, the children (and
their parents) are invited to visit our study center in the
children’s hospital for measurements of growth, body
composition and risk factors for cardiovascular disease
including a full-body DEXA scan, sonographic measure-
ment of abdominal fat, blood pressure measurement,
sonographic measurement of thickness and stiffness of
carotid artery wall, assessment of blood cholesterol and
lipid profiles. Furthermore, lung function is being assessed,
as well as cognitive, mental and behavioral development
[20–22].
In the 16 prenatal and postnatal questionnaires for
mothers/parents, items are included that assess environ-
mental characteristics. This includes indicators of prenatal
and postnatal familial stress, parenting styles and parenting
practices in the family, and characteristics of the home and
neighborhood environment. Observation of the home
environment using a standardized checklist has been done
during a home visit at child age 3 months. The home
address (postal code and house address) is used to link the
Generation R data to municipal data on the environment
including traffic density, environmental noise, air quality,




Of the eligible mothers, 61% provided informed consent in
the first phase of the study (i.e., pregnancy until birth) [20].
In total, 9,778 mothers were enrolled in the study. Of these
mothers, 91% (n = 8,880) were enrolled during pregnancy.
The response rates for the questionnaires during pregnancy
and after birth ranged from 60–70%. Mean age of the
mother at enrollment was 29.7 (SD 5.3). Parity was 0 for
55%, 1 for 31% and [=2 for 14% of the mothers in the
study. Of the participating mothers, 58% were Dutch, 9%
Surinamese, 7% Moroccan, 9% Turkish, 4% were of the
Dutch Antilles, 4% Cape Verdian and 9% of other ethnic
background. Forty-two percent of the participating mothers
had higher vocational training and/or university-level
education [21].
The 9,778 mothers who were enrolled in the study gave
birth to 9,745 known live born children. The follow-up
until age 48 months was restricted to the catchment’s area
of the participating preventive child health centers; 1,163
children lived outside this area and were not eligible for
follow-up in the first 4 years after birth. After birth,
informed consent was renewed; 689 (8%) mothers did not
give consent to the postnatal phase of the study, leaving
7,893 children for the postnatal follow-up until the age of
4 years [21, 22].
DNA
Of the eligible mothers, blood samples for DNA extraction
were available for 91% (8,055). Of the 8,821 eligible
children, cord blood samples were obtained for 67%
(5,908). The relative large number of missing cases for
cord blood was due to logistical constraints during delivery
[21].
It was examined if mothers with and without DNA
availability differ with regard to socio-demographic char-
acteristics and birth characteristics. Only small differences
between mothers and children with and without DNA
availability were observed; the single exception being that
children without DNA availability more often had low
birth weight (\2,500 g 10.8%, respectively, 3.3%) and a
lower gestational age (\37 weeks 11.2%, respectively,
3.9%) relative to those with available DNA [21].
Child DNA extraction was conducted manually using
the Qiagen FlexiGene Kit (Qiagen Hilden, Germany).
DNA extraction from 5-ml whole blood samples from the
mothers and partners was performed by a Hamilton STAR
multi-channel robot using AGOWA magnetic bead tech-
nology (at 72 samples per run). Extracted DNA is auto-
matically collected in stock tubes, but DNA of each subject
can be individually addressed. All genotyping studies with
Generation R DNA material were performed in-house at
the genotyping facility associated with Erasmus Medical
Center [21].
Candidate gene studies in mothers and children:
a template for data analysis
Table 1 outlines our template for data analysis. We propose
to start with assessing the associations with HRQOL out-
comes of the (updated) list of candidate genes that was
prepared by the GENEQOL consortium based on a litera-
ture review regarding genetic factors relating to concepts
that are related to HRQOL, i.e., negative and positive
psychological affect, self-rated physical health, pain and
fatigue [15]. We will thus start with candidate gene studies
on HRQOL of both mothers and young children. An
advantage of the candidate gene approach is that with
single nucleotide polymorphisms (SNPs) with a frequency
of at least 5%, one can expect adequate power to assess
associations with HRQOL outcomes.
Within the Generation R study, genotyping of both
mother and child DNA has been performed for various
specific candidate genes relevant for obesity, diabetes
mellitus type 2, asthma, atopic dermatitis, cortisol secretion
and child psychiatric conditions. Other candidate genes that
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are hypothesized to be involved in pathways influencing
HRQOL may be assessed as well with regard to either
mothers or children, or both.
Since the HRQOL outcomes were measured repeatedly,
growth models may be applied to evaluate distinct trajec-
tories of quality of life scores over time; General Linear
Models may be applied to evaluate associations between
potential determinants and trajectories of quality of life
scores. In addition, the association between potential
determinants and change in quality of life scores over time
can be evaluated using longitudinal multilevel analysis.
This type of analysis takes account of the correlation
between repeated measures on the same subject and allows
for incomplete outcome data [43].
The role of health status in the pathway between genetic
determinants and HRQOL can also be evaluated. For
example, medical conditions such as respiratory disease, or
symptoms such as pain, are likely to affect HRQOL.
Certain genetic factors may influence HRQOL indirectly
through their effect on health status. Gene–environment
interactions will also be explored. In addition to simple
sequence variations, we can evaluate whether changes in
copy number of a small part of the genome, so called copy
number variants (CNVs), are associated with HRQOL
outcomes [15].
Genome-wide association (GWA) studies
The relatively novel strategy of genome-wide association
(GWA) studies is now feasible to determine important
common genetic variants that contribute to the explanation
of variance in relevant phenotypes (such as high or low
HRQOL) [21, 44]. A genome-wide scan (Illumina 610K
platform) of child DNA was taken. A genome-wide scan of
mother DNA has not been scheduled yet.
With regard to child DNA, a multi-stage approach is
being prepared for genome-wide association studies on
prioritized child phenotypes of interest including child
HRQOL. The research strategy will benefit from the
infrastructure used in the GWA analyses in the Rotterdam
Study, a population-based cohort study in about 15,000
Rotterdam adults [45]. First, all SNPs with a P value\10-7
will be selected. Second, these SNPs will be replicated in
(where possible) other cohorts that have data on the same
self-reported and parent-reported outcomes and DNA. In
Generation R, genetic associations will be analyzed in
strata of ethnicity and (pooled) as whole cohort.
The Generation R study groups continue to cooperate
with investigators conducting similar child and birth cohort
studies that include DNA and data on the same or similar
outcomes. Examples include the Avon Longitudinal Study
of Parents and Children (ALSPAC) in Bristol, UK, the
Danish National Birth Cohort Study, the Norwegian
Mother and Child Cohort Study, the Southampton
Women’s Survey (SWS) in Southampton, UK and The
National Children’s Study in the USA [21].
Discussion
It is plausible that genetic factors exist that affect HRQOL
of mothers and children. Genetic factors may have a direct
effect on HRQOL, but it is also possible that genetic fac-
tors influence health status (e.g., disease, severity of
symptoms) and hence affect HRQOL. Also, genetic factors
may interact with environmental factors. This is an illus-
tration of the extended model of Wilson and Cleary, pro-
posed by Sprangers et al., that shows how molecular and
genetic factors influence pathophysiology, symptom status,
functional status, general health perceptions and HRQOL
[46]. This model also shows how both individual charac-
teristics, including molecular and genetic factors, and
environmental characteristics affect each of these steps
from pathophysiology to HRQOL [46].
Since the Generation R cohort, which is derived from a
general population sample, includes a large majority of
healthy mothers and children, with regard to pathophysi-
ologic processes, the focus will be on prevalent conditions
Table 1 A template for data
analysis in candidate gene
studies of HRQOL in mothers
and children
Parameter Action step
Theoretical model Specify pathways influencing HRQOL
Candidate genes Utilize GENEQOL Consortium list based on literature review regarding
genetic factors relating to HRQOL concepts
Statistical modeling Growth models for longitudinal data
General linear models to evaluate associations among potential
determinants and QOL trajectories
Foci Role of health status in pathway between genetics determinants and
HRQOL
Gene–environment interactions
Simple sequence changes and their association with HRQOL
Copy number variants and their association with HRQOL
Qual Life Res (2010) 19:1439–1446 1443
123
and symptoms such as those related to asthma, allergies,
recurrent pain, or common emotional and behavioral dis-
orders. Lubetkin et al. have shown how socio-demographic
factors such as gender, age, education level, ethnic back-
ground and income level as well as the presence of com-
mon chronic conditions each independently affect HRQOL
scores in an adult general population sample [47]. Von
Rueden et al. showed that there are similar associations
between socio-economic factors and childhood HRQOL
[14]. The current study will add whether genetic factors
can be found that independently contribute to HRQOL
scores of both mothers and children, in addition to cur-
rently known determinants. It will be possible to explore
whether certain genetic factors interact with socio-demo-
graphic determinants or common chronic conditions with
regard to the impact on HRQOL.
Until now, there have been very few empirical studies
using either a candidate gene approach or a genome-wide
association approach to assess the genetic basis of
HRQOL. The GENEQOL consortium has proposed a
research agenda to provide more insight into the genetic
disposition of patient-reported quality of life outcomes.
This will require a multi-disciplinary approach. This paper
demonstrates that the Generation R study with 9,778 par-
ticipants in the prenatal phase and 7,893 participants in the
postnatal phase can meaningfully contribute to both can-
didate gene studies of mothers’ and children’s HRQOL and
genome-wide association studies of children’s HRQOL.
Since the Generation R study is a longitudinal study, it
will be possible to explore whether genetic factors, or
genetic factors in interaction with environmental factors,
influence trajectories of HRQOL over time. For this pur-
pose, we will first describe the presence of distinct trajec-
tories of HRQOL over time of both mothers (during
pregnancy and after delivery) and children (from birth until
age 5/6 years), especially in the context of specific (com-
mon) medical conditions such as asthma or allergies.
Secondly, we will evaluate whether genetic and environ-
mental factors are associated with specific trajectories.
Strengths and weaknesses
The Generation R study has relatively many participants.
However, specific analyses will require available quality of
life data as well as data on (child) DNA, reducing the
numbers in the actual analyses. It is an advantage that
Generation R included a multi-ethnic population; yet for
analyses in specific (non-Dutch) ethnic strata, the numbers
are relatively low. This pleads for collaborations with other
cohorts.
Although overall participation in Generation R was
relatively high (60%), it turned out that participants in the
study and in separate measurements are relatively higher
educated, more often of Dutch origin, and more healthy
[20–22]; this needs attention when the associations
between potential determinants and HRQOL outcomes are
different in the subgroup non-participants compared to the
subgroup participants.
Health-related quality of life of both mothers and chil-
dren was measured repeatedly using widely used validated
instruments. However, attention should be given in the
analyses to the potential presence of differential item
functioning by ethnicity (or gender among children) in this
multi-ethnic cohort since this might affect the associations
that may arise.
The parents, generally the mothers, completed the ques-
tionnaires on the children’s HRQOL. Parent characteristics
may influence parents’ reports on their child’s quality of life
[48, 49], which makes evaluation of the associations
between genetic factors and children’s HRQOL more
complex. In the future, when the children grow older, self-
reports on children’s quality of life may be collected.
In the Generation R study, a large number of medical,
psychological and environmental co-variates have been
carefully documented, enabling evaluation of the role of
health status in the pathway between genetic factors and
HRQOL, and the exploration of gene–environment inter-
actions. However, theoretical models should guide the
analyses and attention should be given to the possibility of
chance findings given multiple outcomes and multiple
determinants; results need replication in other cohorts.
Conclusion
Gaining insight into the determinants of HRQOL is
essential to assisting efforts in health policy and clinical
application to improve well-being and health. In the future,
it might be possible to complement HRQOL assessments
by examinations of genetic markers. This might be espe-
cially important in individuals with substantially reduced
HRQOL measurement scores that do not correspond with a
favorable health and life situation and thus cannot be
explained by the classical HRQOL determinants. Specific
medical interventions to enhance genetically determined
low HRQOL of course should be viewed extremely careful.
Beforehand any of such medical interventions could be
considered, it should be considered and examined how far
such genetic disposition can be compensated by strength-
ening other resources of quality of life as strong social
support, social competence and various personal coping
strategies. Specific cognitive interventional or educational
approaches could also focus on training people how to cope
with such a genetic determinant.
It is now feasible to study the association between can-
didate genes and HRQOL outcomes. This can occur in
1444 Qual Life Res (2010) 19:1439–1446
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cohort studies such as the Generation R study, which is an
example of a large birth cohort study with extensive data
with regard to health, determinants of health and HRQOL of
both mothers and children. As a second step, genome-wide
association studies may be performed to find genetic vari-
ants related to HRQOL outcomes. In order to proceed effi-
ciently with genome-wide association studies on HRQOL,
consensus regarding relevant quality of life concepts is
needed as well as collaboration between research centers.
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